Article
Depression and Pharmacogenetics.
Archives of psychiatric nursing - 1 Feb 2018
Ampong David Nana
Abstract excerpt
Depression is the most common and leading devastating psychiatric illness that affects a majority of the world population. The treatment of depression has been a challenge for a majority of patients and healthcare practitioners. The advent of pharmacogenomics (PGx) empowered the Food and Drug Administration to approve some antidepressant biomarkers for PGx model of treatment. The PGx testing identifies whether an...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
